Caris Life Sciences (CAI) Receivables - Other (2024 - 2025)
Caris Life Sciences has reported Receivables - Other over the past 2 years, most recently at $7.2 million for Q4 2025.
- Quarterly results put Receivables - Other at $7.2 million for Q4 2025, up 56.52% from a year ago — trailing twelve months through Dec 2025 was $7.2 million (up 56.52% YoY), and the annual figure for FY2025 was $7.2 million, up 56.52%.
- Receivables - Other for Q4 2025 was $7.2 million at Caris Life Sciences, down from $9.9 million in the prior quarter.
- Over the last five years, Receivables - Other for CAI hit a ceiling of $11.2 million in Q2 2025 and a floor of $4.6 million in Q4 2024.